MedTrace Logo

Diagnosis of Epithelial Ovarian Cancer Using Ovarian Cancer Score (OCS) Test

NCT06366997 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1352

Last updated 2024-04-16

No results posted yet for this study

Summary

The study is designed to confirm the performance of the 3D Medicines Corporation OCS test in diagnosis of epithelial ovarian cancer in patients with adnexal mass. To this end, blood samples from female patients with adnexal mass required surgical resection from four centers are obtained and analysis in the study.

Conditions

  • Epithelial Ovarian Cancer
  • Adnexal Mass

Sponsors & Collaborators

  • Zhejiang Cancer Hospital

    collaborator OTHER

  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

    collaborator OTHER

  • The First Affiliated Hospital of Zhengzhou University

    collaborator OTHER

  • 3D Medicines Corporation

    collaborator UNKNOWN

  • Chongqing University Cancer Hospital

    lead OTHER

Principal Investigators

  • Qi Zhou · Chongqing University Cancer Hospital

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-09
Primary Completion
2023-04-18
Completion
2023-05-05

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06366997 on ClinicalTrials.gov